Login
Products
Login
Home
Alerts
Search
Watchlist
Products

EPL Ltd

EPL
NSE
226.94
0.71%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

EPL Ltd

EPL
NSE
226.94
0.71%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
7,268Cr
Close
Close Price
226.94
Industry
Industry
Packaging - FMCG/Consumers
PE
Price To Earnings
18.13
PS
Price To Sales
1.59
Revenue
Revenue
4,568Cr
Rev Gr TTM
Revenue Growth TTM
10.42%
PAT Gr TTM
PAT Growth TTM
54.37%
Peer Comparison
How does EPL stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
EPL
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
9699101,0029751,0291,0071,0861,0141,1051,1081,2061,149
Growth YoY
Revenue Growth YoY%
10.19.45.63.26.210.78.44.07.410.011.013.3
Expenses
ExpensesCr
815751821792838822866813877881954918
Operating Profit
Operating ProfitCr
155159181183191186221202228227252231
OPM
OPM%
15.917.518.118.818.618.420.319.920.620.520.920.1
Other Income
Other IncomeCr
27111125-4461213118122
Interest Expense
Interest ExpenseCr
212431293229292728282929
Depreciation
DepreciationCr
798084848584858688909497
PBT
PBTCr
826678943080118101123117141107
Tax
TaxCr
-31125715143067163524
PAT
PATCr
855652871566889411610110683
Growth YoY
PAT Growth YoY%
69.958.99.438.6-82.318.269.57.8666.254.320.2-11.7
NPM
NPM%
8.86.15.28.91.56.58.19.310.59.28.87.2
EPS
EPS
2.61.71.62.70.72.02.72.93.63.13.32.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
2,3232,1282,3022,4242,7072,7613,0923,4333,6943,9164,2134,568
Growth
Revenue Growth%
9.2-8.48.25.311.72.012.011.07.66.07.68.4
Expenses
ExpensesCr
1,9321,7241,8801,9592,2082,2042,4812,8573,1163,2023,3773,631
Operating Profit
Operating ProfitCr
391404422465499558611576578714836937
OPM
OPM%
16.819.018.319.218.420.219.816.815.618.219.820.5
Other Income
Other IncomeCr
26315220373-343824233
Interest Expense
Interest ExpenseCr
796158556156434067116114114
Depreciation
DepreciationCr
132123141167186230235251281333343368
PBT
PBTCr
206251274263289275331289268268422488
Tax
TaxCr
617879899364876837585882
PAT
PATCr
145173196174195212244221231210364406
Growth
PAT Growth%
29.919.413.0-10.912.28.315.4-9.44.3-8.973.211.7
NPM
NPM%
6.28.18.57.27.27.77.96.56.35.48.68.9
EPS
EPS
4.55.46.12.76.16.67.66.87.26.711.312.5

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
313131316363636364646464
Reserves
ReservesCr
7299331,0081,2191,3251,4701,6351,7611,9262,0282,2912,560
Current Liabilities
Current LiabilitiesCr
6264435456665747927738969631,0841,1521,329
Non Current Liabilities
Non Current LiabilitiesCr
665603669522553472507537677634495500
Total Liabilities
Total LiabilitiesCr
2,0602,0192,2592,4422,5202,8063,0113,2913,6323,8094,0064,460
Current Assets
Current AssetsCr
1,0049229641,1341,0931,3401,3441,5321,6231,6471,7342,004
Non Current Assets
Non Current AssetsCr
1,0551,0971,2951,3081,4271,4661,6671,7592,0102,1622,2712,455
Total Assets
Total AssetsCr
2,0602,0192,2592,4422,5202,8063,0113,2913,6323,8094,0064,460

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
313361369343356471522312602587795
Investing Cash Flow
Investing Cash FlowCr
-145-46-301-156-188-119-281-264-389-344-376
Financing Cash Flow
Financing Cash FlowCr
-168-320-76-154-194-142-319-95-138-263-431
Net Cash Flow
Net Cash FlowCr
0-5-934-25210-77-4874-21-12
Free Cash Flow
Free Cash FlowCr
11416516220656364526320606589802
CFO To PAT
CFO To PAT%
215.8208.4188.5197.2182.4222.6213.8140.8260.9279.1218.6
CFO To EBITDA
CFO To EBITDA%
80.189.487.473.971.484.585.554.1104.282.195.1

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,9592,5303,7253,7813,6804,8777,4366,1145,1525,6706,460
Price To Earnings
Price To Earnings
15.214.919.622.019.123.531.128.622.726.618.0
Price To Sales
Price To Sales
0.81.21.61.61.41.82.41.81.41.41.5
Price To Book
Price To Book
2.52.63.63.02.63.24.43.42.62.72.7
EV To EBITDA
EV To EBITDA
6.77.610.29.08.39.212.811.610.08.98.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
51.156.656.257.257.058.158.255.854.757.758.8
OPM
OPM%
16.819.018.319.218.420.219.816.815.618.219.8
NPM
NPM%
6.28.18.57.27.27.77.96.56.35.48.6
ROCE
ROCE%
18.719.719.217.217.815.416.012.711.712.817.0
ROE
ROE%
19.117.918.813.914.113.814.412.111.610.115.4
ROA
ROA%
7.08.68.77.17.87.58.16.76.35.59.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** EPL Ltd (formerly Essel Propack Limited) is the **world’s largest manufacturer of laminated plastic tubes**, serving the **FMCG and pharmaceutical industries** across **10–11 countries** through **20–21 advanced manufacturing facilities**. The company produces over **8 billion tubes annually** and is a global leader in specialty packaging solutions, with a strong footprint in **Oral Care, Beauty & Cosmetics, Pharma & Health, Food, and Home Care** segments. With more than **5,700 employees from over 24 nationalities**, EPL operates globally across **AMESA (Africa, Middle East, South Asia), EAP (East Asia-Pacific), Europe, and the Americas**. It has evolved from an oral care-focused business to a diversified packaging leader, with **over 50% of revenue now derived from non-oral categories**, especially **Beauty & Cosmetics (B&C)**. --- ### **Strategic Growth & Market Position** #### **1. Leading Market Share & Diversified Portfolio** - Holds #1 position in **global oral care packaging**, supplying **one in every three toothpaste tubes** worldwide. - Leading global market share (~36%) in oral care, with growing wallet share among top FMCG clients including **Colgate, P&G, Unilever, GSK, Johnson & Johnson, and Haleon**. - The **‘Personal Care & Beyond’** segment (Beauty & Cosmetics, Pharma, Food, Home) now accounts for **over 50% of total revenue**, growing at a **~13% CAGR over the past 14 years**. - Beauty & Cosmetics has emerged as the primary growth engine, with **double-digit revenue growth for two consecutive quarters in 2025**. #### **2. Geographic Expansion** - Manufacturing footprint spans the **USA, Mexico, Colombia, Brazil, Poland, Germany, Egypt, China, Philippines, Indonesia, and India**. - Strategic **greenfield projects** launched: - **Thailand plant inaugurated in Nov 2025**, built in **9 months**, targeting Southeast Asia exports. - **Brazil plant stabilized and growing rapidly**, already margin-accretive, serving anchor and new multinational customers. EPL is the **only strategic global tube supplier in Brazil**, giving it a first-mover advantage. - **Local-for-local manufacturing** model minimizes trade risks—tubes sold in the **U.S. are made in the U.S.**, avoiding import tariffs. #### **3. Targeted Growth in High-Potential Markets** - **Europe**: Low market share (~4% in B&C) indicates significant upside; strategic leadership changes and M&A evaluation underway to accelerate penetration. - **China & East Asia Pacific**: Export hub, growing at **20% YoY over five years**, with strong momentum despite macro volatility. - **India**: Strategic base for innovation and cost leadership, with expanding presence in pharma, beauty, and hygiene. --- ### **Innovation & Technology Leadership** #### **1. Proprietary Product Innovations** - **Platina Series**: World’s **first 100% recyclable laminated tube** (including cap and shoulder), certified by **APR (USA)** and **RecyClass Europe (Code 2 HDPE)**. - Accounts for **38% of total production volume** in 2025. - Key clients: **Colgate, Haleon, Sunsilk, Unilever, P&G**. - **Neo Seam™ Technology**: - Eliminates side seam visibility for 360° printing, matching extruded tube aesthetics. - **EBITDA margin accretive**, commercialized globally, driving B&C growth. - Supports entry into niche formats (e.g., spring masks, glucose tubes, anti-itch ointments). - **eMetal Printing**: First-in-industry **metal deposit printing without PE liner**, enhancing sustainability and visual impact. - **New Formats**: Tube-in-tube, precise dosage control tubes, airless pump tubes, sculpting roller tubes, and dry hair gel packaging. #### **2. Advanced Manufacturing Capabilities** - End-to-end **integrated manufacturing**: Film extrusion, lamination, printing (flexo, digital, foil), tube forming, cap molding. - **Digital printing capacity expanded globally**, with **HP Indigo 8K presses**, enabling **personalization, small MOQs, and rapid turnaround**. - State-of-the-art **16-station extrusion machines** and **9-layer blown film lines** enhance quality and capacity. - SAP **S/4HANA** runs across all global facilities; digitization via **ePAD (shopfloor automation), eACT (digital artwork collaboration)**, and AI/ML for process optimization. #### **3. Sustainability Leadership** - Achieved **EcoVadis Platinum rating (Nov 2025)**—top 1% of 150,000 assessed companies globally. - **38% of total production is recyclable**, with 50% of offerings designed for **HDPE recyclability**. - Key initiatives: - **Project Liberty**: Full recyclability of **aluminum-based laminated (ABL) tubes** via polymer-aluminum separation. - **Green Maple Leaf & Etain tubes**: Made with **post-consumer recycled (PCR) resin**, targeting food and cosmetics. - Carbon footprint reduction through **thin-wall designs, waste minimization (War on Waste)**, and renewable energy (e.g., 49% stake in Clean Max Aria for wind/solar power). --- ### **Commercial & Sales Strategy** #### **1. Dual Sales Model** - **Key Account Management**: For large oral care clients. - **Frontline Sales Expansion**: Dedicated "hunting" teams added (+20% headcount) to target **smaller, fragmented B&C customers**, especially in Europe and the Americas. - Focus on **agility, innovation, and shorter lead times** for small-volume, high-mix orders. #### **2. Market Transformation** - Driving format shifts: - **Bottles → tubes**: Honey, hair gel. - **Aluminum → co-extruded acrylic & laminated tubes**: Sustainability and performance upgrade. - **Rigid packaging → tubes**: Food, home care, pet care (e.g., cat/dog lice treatment). #### **3. M&A & Partnerships** - **Strategic M&A agenda** in **Beauty & Cosmetics** and **extruded tubes**, focusing on **Europe** for market entry. - **Indorama Ventures (IVL)** invested in EPL (Mar 2025), validating its model and enabling **expansion into Southeast Asia and Africa** via IVL’s regional strength. - Acquired **CSPL (Creative Stylo Packs)**, enhancing plastic extrusion and cap molding capabilities. - Joint ventures in **Indonesia** and **Germany (EDG)** extend geographic reach. --- ### **Recent Developments (2025)** - Inaugurated **Thailand plant**—strategic SE Asia gateway. - Expanded **60mm diameter tube manufacturing**. - Won business in **Brazil, Thailand, Australia, Taiwan, Myanmar**. - Commercialized **Precise Dosage Control Tubes, Tube-in-Tube, spring masks**. - Strengthened **digital showroom, AI tools, and ePAD rollout** in USA, Mexico, Colombia. ---